IRVING, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) — As Texas continues to grow as a biotech and healthcare innovative hub, BioNTX is honored to announce the 2024 Rising Stars, a select group of pioneering companies that will be formally recognized at the upcoming iC³® Life Science & Healthcare Innovation Summit in Arlington, Texas on Thursday, October 3rd and Friday October 4th. These companies have been meticulously chosen by the life sciences community for their outstanding potential to drive significant change through innovation and tenacity to address the most pressing challenges we face in healthcare and life sciences.
“The life science ecosystem in North Texas is growing rapidly and the Rising Stars play a significant role in its growth. Two examples of previous Rising Stars recipients are Lantern Pharma and Colossal Biosciences. Since being honored, Lantern Pharma is now publicly traded and Colossal has spun-out Form Bio. In addition, large exits such as Reata Pharmaceuticals and Peloton Therapeutics have shown us that North Texas has emerged as a player in this space. It also confirms our Rising Stars have the resources and talent locally to be successful on a national and global level,” says Logan Atkins, Financial Advisor at The Davis/Yost Group at Morgan Stanley.
The 2024 Rising Stars are recognized for their groundbreaking advancements and unwavering commitment to pushing the boundaries in the bioscience and healthcare innovation arena because patients cannot wait. These companies have demonstrated exceptional success in innovation, disruption, and leadership, setting themselves apart in a highly competitive and rapidly evolving landscape.
The 2024 Rising Star recipients are:
- Almaden Genomics
- CorInnova
- GenrAb
- Island Pharmaceuticals
- Opsin Biotherapeutics
- Panthera BioSolutions
- SingleCell Biotechnology
- Solenic Medical
“Every year, we are thrilled to learn more about the amazing work that biotech and healthcare innovation companies are doing in our region and have the opportunity to recognize a few notable organizations at our iC³ Life Science & Healthcare Innovation Summit,” says Kathleen Otto, CEO of BioNTX. “We look forward to hearing from our 2024 Rising Stars at the Summit and continue to watch the advancements each of these special companies make.”
Each 2024 Rising Stars company will share information about their company, achievements and insight into the industry at this year’s iC³ Life Science & Healthcare Innovation Summit on October 3-4, 2024. Registration for the Summit can be completed here.
About the 2024 iC3 Life Science Summit
The 10th Annual BioNTX iC³ Life Science & Healthcare Innovation Summit brings together bioscience and healthcare innovation leaders for a two-day event from Thursday, October 3rd – Friday, October 4th. The iC³ Summit fosters collaboration between thought leaders, knowledge exchange, and explores the latest innovation, products, and services in the life sciences. We invite you to register for the 2024 iC³ Life Science Summit, please click here.
About The Davis/Yost Group at Morgan Stanley
At The Davis/Yost Group, we’re a highly experienced team of financial professionals with diverse backgrounds and a common focus: everything we do begins and ends with a commitment to helping you realize your dreams and ambitions. That’s why we work tirelessly to provide our select clientele of accomplished entrepreneurs and executives – as well as their families, foundations, and businesses – with highly customized blueprints for success. In many cases, our clients’ business and personal finances are closely intertwined and highly complex. Working to create holistic solutions, we address both personal and business financial issues and opportunities. We provide access to an extensive professional network and maintain close connectivity with Morgan Stanley’s Capital Markets and Investment Banking Divisions, as well as to the middle market banks the firm has contracted. We are as comfortable helping you with a capital raise or corporate loan as we are discussing investment opportunities, wealth transfer approaches and philanthropic strategies. Our team can offer the resources, expertise and global connections needed to make informed financial decisions; ones that have far-reaching implications on both business goals and personal wealth.
About BioNTX
BioNTX is the bioscience and healthcare innovation trade organization serving North Texas. The organization fosters innovation and community through collaborative networking events, high-level educational programming, professional development, market visibility, a purchasing consortium, and by being the voice for the North Texas biosciences and healthcare innovation community.
Media Contact:
Allison Chaney
Culver Public Relations
214-352-5980
allison@culverpr.com
- Rocky Shore Announces Closing of Hemlo Area Claims Sale - July 4, 2025
- A Letter from the company’s shareholder regarding the intention to submit a tender offer, aimed at delisting the shares of the company from trading on AB Nasdaq Vilnius was received - July 4, 2025
- Sonoro Gold Secures All Surface Rights for the PROPOSED Cerro Caliche MINING OPERATION - July 4, 2025
